ASTROTECH Corp (ASTC) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-03-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-03-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 6.98M USD | Research and Development Expense |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 941.00K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -13.81M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $6.98M | (m) | $941.00K | $-13.81M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $7.53M | (m) | $846.00K | $-14.22M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $8.14M | (m) | $918.00K | $-14.64M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $8.14M | $1.00M | $830.00K | $-14.73M | (m) | 814.20% | 83.00% | (m) | (m) |
| 2025-03-31 | $8.01M | (m) | $832.00K | $-15.16M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $7.73M | (m) | $1.12M | $-14.83M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $6.87M | (m) | $1.33M | $-13.57M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $6.79M | $1.70M | $1.48M | $-13.28M | (m) | 399.41% | 86.94% | (m) | (m) |
| 2024-03-31 | $6.90M | (m) | $1.63M | $-12.67M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $6.55M | (m) | $1.54M | $-11.88M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $6.33M | (m) | $1.48M | $-11.63M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $5.59M | $750.00K | $1.50M | $-11.06M | (m) | 745.47% | 199.73% | (m) | (m) |
| 2023-03-31 | $4.62M | (m) | $1.52M | $-10.46M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $3.98M | (m) | $1.53M | $-9.86M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $3.27M | (m) | $1.56M | $-9.31M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $2.78M | $869.00K | $1.53M | $-8.60M | (m) | 320.02% | 176.64% | (m) | (m) |
| 2022-03-31 | $2.67M | (m) | (m) | $-8.42M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $2.62M | $812.00K | $1.33M | $-8.61M | (m) | 322.17% | 164.29% | (m) | (m) |
| 2021-09-30 | $2.72M | $387.00K | $941.00K | $-7.91M | (m) | 703.36% | 243.15% | (m) | (m) |
| 2021-06-30 | $2.69M | $334.00K | $626.00K | $-7.91M | (m) | 805.99% | 187.43% | (m) | (m) |
| 2021-03-31 | $2.87M | $488.00K | $350.00K | $-7.97M | (m) | 587.09% | 71.72% | (m) | (m) |
| 2021-03-21 | (m) | (m) | $350.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $3.01M | $552.00K | $251.00K | $-7.63M | (m) | 545.29% | 45.47% | (m) | (m) |
| 2020-09-30 | $3.19M | $621.00K | $288.00K | $-8.11M | (m) | 513.85% | 46.38% | (m) | (m) |
| 2020-06-30 | $3.44M | $488.00K | $348.00K | $-8.11M | (m) | 704.30% | 71.31% | (m) | (m) |
| 2020-03-31 | $3.16M | $411.00K | $382.00K | $-7.85M | (m) | 768.61% | 92.94% | (m) | (m) |
| 2019-12-31 | $3.37M | $293.00K | $394.00K | $-8.11M | (m) | 1150.85% | 134.47% | (m) | (m) |
| 2019-09-30 | $3.33M | $95.00K | $373.00K | $-8.25M | (m) | 3505.26% | 392.63% | (m) | (m) |
| 2019-06-30 | $3.58M | $127.00K | $305.00K | $-8.42M | (m) | 2817.32% | 240.16% | (m) | (m) |
| 2019-03-31 | $4.37M | $85.00K | $268.00K | $-10.90M | (m) | 5142.35% | 315.29% | (m) | (m) |
| 2018-12-31 | $4.84M | $85.00K | $306.00K | $-11.49M | (m) | 5692.94% | 360.00% | (m) | (m) |
| 2018-09-30 | $5.50M | $119.00K | $364.00K | $-12.49M | (m) | 4621.01% | 305.88% | (m) | (m) |
| 2018-06-30 | $6.07M | $86.00K | $450.00K | $-13.34M | (m) | 7052.33% | 523.26% | (m) | (m) |
| 2018-03-31 | $6.20M | $432.00K | $486.00K | $-11.96M | (m) | 1435.42% | 112.50% | (m) | (m) |
| 2017-12-31 | $6.27M | $843.00K | $422.00K | $-12.05M | (m) | 743.42% | 50.06% | (m) | (m) |
| 2017-09-30 | $5.96M | $1.32M | $394.00K | $-11.57M | (m) | 451.13% | 29.80% | (m) | (m) |
| 2017-06-30 | $5.59M | $2.33M | $1.13M | $-12.06M | (m) | 239.99% | 48.71% | (m) | (m) |
| 2017-03-31 | $6.08M | $3.48M | $1.16M | $-12.85M | (m) | 174.55% | 33.40% | (m) | (m) |
| 2016-12-31 | $6.42M | $3.27M | $1.26M | $-13.84M | (m) | 196.48% | 38.41% | (m) | (m) |
| 2016-09-30 | $6.50M | $3.68M | $1.27M | $-13.85M | (m) | 176.69% | 34.54% | (m) | (m) |
| 2016-06-30 | $6.47M | $2.67M | $551.00K | $-13.84M | (m) | 242.19% | 20.63% | (m) | (m) |
| 2016-03-31 | $5.39M | $1.30M | $5.39M | $-18.37M | (m) | 414.77% | 414.77% | (m) | (m) |
| 2015-12-31 | $4.15M | $1.12M | $5.27M | $-16.76M | (m) | 371.68% | 472.49% | (m) | (m) |
| 2015-09-30 | $3.81M | $193.00K | $5.17M | $-17.05M | (m) | 1972.02% | 2678.76% | (m) | (m) |
| 2015-06-30 | $3.23M | $513.00K | $5.03M | $-16.11M | (m) | 630.41% | 980.12% | (m) | (m) |
| 2015-03-31 | $3.04M | $16.63M | $83.00K | $-6.94M | (m) | 18.28% | 0.50% | (m) | (m) |
| 2014-12-31 | $3.02M | $16.66M | $45.00K | $-6.64M | (m) | 18.15% | 0.27% | (m) | (m) |
| 2014-09-30 | $2.39M | $10.05M | $631.00K | $-5.93M | (m) | 23.79% | 6.28% | (m) | (m) |
| 2014-06-30 | $2.50M | $16.42M | $646.00K | $-5.68M | (m) | 15.25% | 3.93% | (m) | (m) |
| 2014-03-31 | $2.39M | $19.96M | $620.00K | $-2.59M | (m) | 11.96% | 3.11% | (m) | (m) |
| 2013-12-31 | $2.20M | $22.97M | $634.00K | $196.00K | (m) | 9.58% | 2.76% | (m) | (m) |
| 2013-09-30 | $2.24M | $24.56M | $65.00K | $2.02M | (m) | 9.13% | 0.26% | (m) | (m) |
| 2013-06-30 | $2.08M | $24.00M | $31.00K | $-559.00K | (m) | 8.67% | 0.13% | (m) | (m) |
| 2013-03-31 | $2.09M | $22.42M | $208.00K | $-3.19M | (m) | 9.30% | 0.93% | (m) | (m) |
| 2012-12-31 | $2.10M | $27.87M | $407.00K | $-2.03M | (m) | 7.54% | 1.46% | (m) | (m) |
| 2012-09-30 | $2.46M | $27.43M | $645.00K | $-3.04M | (m) | 8.95% | 2.35% | (m) | (m) |
| 2012-06-30 | $2.57M | $26.14M | $1.01M | $-2.29M | (m) | 9.84% | 3.85% | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $3.83M | $20.15M | $1.20M | $-5.75M | (m) | 19.03% | 5.93% | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |